Medication info

Valsartan Tablets 80 mg (Valsartan)

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›80mg / 1 tablet
Manufacturer / importer
Hanol Bio Pharma Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201208109 · Approved 2012.11.13

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension, reduction of the risk of death after myocardial infarction, and treatment of heart failure
Who takes it
Adults · Children
Adult dose
1. Essential hypertension Take with water during a meal or between meals. If possible, it is recommended to take the drug at the same time each day (e.g., in the morning). 1) Adults: Regardless of sex or race, valsartan 80 mg orally once daily is recommended. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum effect after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg once daily or a diuretic may be co-administered. If additional blood pressure reduction is needed, the dose may be increased up to a maximum of 320 mg once daily. 2) Elderly patients (75 years or older): Initiate treatment with this drug at 40 mg once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is required. (2) Creatinine clearance 10 ∼ 20 mL/min: Initiate treatment with this drug at 40 mg once daily. (3) Creatinine clearance below 10 mL/min and patients on dialysis: Do not administer this drug. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), initiate treatment with this drug at 40 mg once daily. 5) Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, initiate treatment with this drug at 40 mg once daily; do not exceed 80 mg daily. Do not administer this drug to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended initial dose is 40 mg of this drug orally twice daily; it may be increased to 80 mg or 160 mg per dose. When co-administering a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, given in divided doses. Triple combination therapy with this drug, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of risk of death after myocardial infarction Adults: Treatment may be started within 12 hours of the onset of myocardial infarction. The recommended initial dose is 20 mg of this drug twice daily, followed over several weeks by dose increases, as tolerated by the patient, to 40 mg, 80 mg, and 160 mg per dose twice daily. Consider dose reduction if symptoms of hypotension or renal impairment occur. This drug may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with ACE inhibitors is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for creatinine clearance of 10 mL/min or more; however, do not administer this drug to patients with creatinine clearance below 10 mL/min or patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of this drug should preferably not exceed 80 mg. If administering 80 mg or more daily, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this drug to patients with severe hepatic impairment, cirrhosis, or cholestasis.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy have not been established in children and adolescents younger than 18 years. 6. Children: The safety and efficacy have not been established in children and adolescents younger than 18 years.

Ingredients

Manufacturer
Hanol Bio Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, reduction of the risk of death after myocardial infarction, and treatment of heart failure

  • Essential hypertension
  • heart failure
  • left ventricular dysfunction
  • left ventricular systolic dysfunction
View approved original text

This medication is primarily used to treat essential hypertension and can also be used safely in heart failure patients who are intolerant to ACE inhibitors (especially in cases classified as NYHA class II to IV). Furthermore, it helps reduce the risk of mortality in patients with left ventricular dysfunction after myocardial infarction. This medication effectively controls blood pressure, reduces the burden on the heart, improves symptoms of heart failure, and helps prevent complications following myocardial infarction. Therefore, it is used for managing hypertension, improving symptoms of heart failure, and reducing the risk after myocardial infarction.

How to take

Adult dose

1. Essential hypertension Take with water during a meal or between meals. If possible, it is recommended to take the drug at the same time each day (e.g., in the morning). 1) Adults: Regardless of sex or race, valsartan 80 mg orally once daily is recommended. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum effect after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg once daily or a diuretic may be co-administered. If additional blood pressure reduction is needed, the dose may be increased up to a maximum of 320 mg once daily. 2) Elderly patients (75 years or older): Initiate treatment with this drug at 40 mg once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is required. (2) Creatinine clearance 10 ∼ 20 mL/min: Initiate treatment with this drug at 40 mg once daily. (3) Creatinine clearance below 10 mL/min and patients on dialysis: Do not administer this drug. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), initiate treatment with this drug at 40 mg once daily. 5) Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, initiate treatment with this drug at 40 mg once daily; do not exceed 80 mg daily. Do not administer this drug to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended initial dose is 40 mg of this drug orally twice daily; it may be increased to 80 mg or 160 mg per dose. When co-administering a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, given in divided doses. Triple combination therapy with this drug, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of risk of death after myocardial infarction Adults: Treatment may be started within 12 hours of the onset of myocardial infarction. The recommended initial dose is 20 mg of this drug twice daily, followed over several weeks by dose increases, as tolerated by the patient, to 40 mg, 80 mg, and 160 mg per dose twice daily. Consider dose reduction if symptoms of hypotension or renal impairment occur. This drug may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with ACE inhibitors is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for creatinine clearance of 10 mL/min or more; however, do not administer this drug to patients with creatinine clearance below 10 mL/min or patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of this drug should preferably not exceed 80 mg. If administering 80 mg or more daily, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this drug to patients with severe hepatic impairment, cirrhosis, or cholestasis.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy have not been established in children and adolescents younger than 18 years. 6. Children: The safety and efficacy have not been established in children and adolescents younger than 18 years.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. Individuals with allergic reactions to this medication, pregnant or nursing women, patients with severely impaired liver or kidney function, and patients with hereditary angioedema should avoid using it. Elderly individuals or those with hyperkalemia, weak liver function, or heart or kidney problems should use this medication with particular caution, starting at a lower dose and gradually increasing it while monitoring their condition. This medication can cause rapid drops in blood pressure, leading to dizziness or fainting upon initial use; if these symptoms occur, use should be stopped immediately and medical attention sought. Patients undergoing hemodialysis or taking diuretics, as well as those on restricted sodium intake, need to be closely monitored when taking this medication. Taking potassium-sparing diuretics or potassium supplements alongside this medication may lead to dangerously high potassium levels, so consultation with a healthcare professional is necessary. Co-administration with other antihypertensives, anti-inflammatory pain relievers, or lithium can lead to interactions, so all medications being taken should be disclosed to the physician. This medication is not recommended for nursing women, and if it must be used, breastfeeding should be discontinued for safety. Safety in children and adolescents has not been established, so it is advisable not to use it in those under 18. Overdose can result in decreased consciousness, hypotension, shock, etc., requiring immediate emergency treatment, and appropriate care such as inducing vomiting or administering normal saline is necessary. This medication should be kept out of reach of children, and not transferred to other containers to help maintain its quality. Regularly monitoring blood pressure, kidney function, electrolyte levels, etc., while on this medication is essential.

Side effects

headache

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and moisture. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.